| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5590843 | Multiple Sclerosis and Related Disorders | 2017 | 6 Pages |
Abstract
Despite a reduction in the relapse rate during pregnancy, the presence of relapses during pregnancy predicted postpartum relapses, with impact on disability. DMT appeared to have no influence on clinical or obstetrical outcome. MS did not have a deleterious effect on the pregnancy course. CD and EA were safe procedures, with a tendency towards CD in MS patients, compared to Portuguese women in general. Breastfeeding did not influence MS activity.
Keywords
ARRIVIginfEDSSDMTinterferonIntravenous immunoglobulinPregnancyepidural analgesiaBirth asphyxiadisease modifying therapyDeliverycaesarean deliveryVaginal deliveryWorld Health Organizationspontaneous abortionBreastfeedingIntramuscularfetal deathExpanded Disability Status ScaleMultiple sclerosisannualized relapse rateNewbornsBirth weightWHOglatiramer acetate
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Joana Jesus-Ribeiro, Inês Correia, Ana Inês Martins, Manuel Fonseca, Inês Marques, Sónia Batista, Carla Nunes, Carmo Macário, Maria Céu Almeida, LÃvia Sousa,